B
Bo Carlberg
Researcher at Umeå University
Publications - 118
Citations - 5768
Bo Carlberg is an academic researcher from Umeå University. The author has contributed to research in topics: Blood pressure & Stroke. The author has an hindex of 33, co-authored 101 publications receiving 5174 citations. Previous affiliations of Bo Carlberg include University of Gothenburg.
Papers
More filters
Journal ArticleDOI
Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.
TL;DR: It is believed that beta blockers should not remain first choice in the treatment of primary hypertension and should not be used as reference drugs in future randomised controlled trials of hypertension.
Journal ArticleDOI
Atenolol in hypertension: is it a wise choice?
TL;DR: The results cast doubts on atenolol as a suitable drug for hypertensive patients and challenge the use of atenolia as a reference drug in outcome trials in hypertension.
Journal ArticleDOI
Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Lars H Lindholm,Mats A. A. Persson,Petar Alaupovic,Bo Carlberg,Anders Svensson,Ola Samuelsson +5 more
TL;DR: Antihypertensive treatment with a diuretic, if needed combined with a β-adrenoceptor blocker, was associated with an aggravated metabolic profile; this was not so for patients treated with an angiotensin-II-receptor blocker as well as in newly diagnosed patients with primary hypertension.
Journal ArticleDOI
Epidemiology and Etiology of Ischemic Stroke in Young Adults Aged 18 to 44 Years in Northern Sweden
Bo Kristensen,Jan Malm,Bo Carlberg,Birgitta Stegmayr,Christer Backman,Markku Fagerlund,Tommy Olsson +6 more
TL;DR: The incidence rate for ischemic stroke was higher than previously reported from most countries in Western Europe and was not explained by a higher prevalence of premature atherosclerotic vasculopathy.
Journal ArticleDOI
Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis
Mattias Brunström,Bo Carlberg +1 more
TL;DR: Primary preventive BP lowering is associated with reduced risk for death and CVD if baseline SBP is 140 mm Hg or higher, and at lower BP levels, treatment is not associated with any benefit in primary prevention but might offer additional protection in patients with CHD.